+449.6%
MRNA vs GLXY
+2.7%
+446.9%
-35.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GLXY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -4.1% | +4.8% | +2.1% |
| 7D | -8.2% | -8.9% | +0.7% | -5.4% |
| 30D | +125.6% | +19.9% | +105.7% | +112.5% |
| 3M | +197.1% | -20.0% | +217.0% | +203.2% |
| 6M | +148.5% | +10.5% | +138.0% | +131.8% |
| YTD | +363.3% | +7.9% | +355.4% | +324.5% |
| 1Y | +462.0% | -7.5% | +469.5% | +425.4% |
| All | +449.6% | +2.7% | +446.9% | +396.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GLXY.
Daily Out/Under-Performance
Portfolio return minus GLXY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GLXY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GLXY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling